Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

INTRODUCTION: Angiogenesis is an important factor in the development of osteoarthritis (OA). We investigated the efficacy of bevacizumab, an antibody against vascular endothelial growth factor and an inhibitor of angiogenesis, in the treatment of OA using a rabbit model of anterior cruciate ligament...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Nagai, Toshihiro, Sato, Masato, Kobayashi, Miyuki, Yokoyama, Munetaka, Tani, Yoshiki, Mochida, Joji
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4189677/
https://ncbi.nlm.nih.gov/pubmed/25230745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-014-0427-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk